| A Comparison of Long-Acting Injectable Medications for Schizophrenia (ACLAIMS) |
25 |
360 |
Randomized, double-masked comparative effectiveness clinical trial |
|
|
Columbia Univ, NIMH |
| Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) |
|
|
|
|
|
|
| ARIC Carotid MRI (CARMRI) |
4 |
2,066 |
Cross-sectional and prospective design |
|
|
NHLBI |
| ARIC MRI and Neurocognitive Longitudinal Study (ARIC MRI) |
2 |
1,134 |
Prospective cohort follow-up |
|
|
NHLBI |
| ARIC Neurocognitive Study (ARIC-NCS) |
4 |
8,600 |
Observational study |
|
|
NHLBI |
| Asymptomatic Carotid Atherosclerosis Study (ACAS) |
37 |
1,500 |
Randomized, unmasked trial |
|
|
|
| Atherosclerosis Risk in Communities (ARIC) |
4 |
15,792 |
Prospective cohort follow-up |
|
|
NHLBI |
| Back Pain Consortium Research Program (BACPAC) |
|
|
|
|
|
NIAMS |
| Bronchiectasis Research Registry (BRON) |
11 |
|
Patient Registry |
|
|
COPD Foundation |
| Cholesterol Reduction in Seniors Program (CRISP) |
5 |
400 |
Randomized, double-masked pilot study |
|
|
NHLBI |
| Combining Medications and Behavioral Interventions (COMBINE) |
11 |
1,380 |
Randomized 2x2x2 factorial trial |
|
|
NIAAA |
| Comparison of Antipsychotics for Metabolic Problems (CAMP) |
26 |
300 |
Randomized, open-label placebo-controlled clinical trial |
|
|
NHLBI |
| Comparison of Depression Interventions after Acute Coronary Syndrome (CODIACS) |
5 |
150 |
Randomized, single-masked clinical trial |
|
|
NHLBI |
| Comparison of Optimal Antipsychotic Treatments for Schizophrenia (COATS) |
15 |
90 |
Randomized, open-label clinical trial |
|
|
NIMH |
| Dietary Effects on Lipoproteins and Thrombogenic Activity (DELTA, DELTA-1, DELTA-2) |
4 |
103, 85 |
2 Randomized, double-masked trials |
|
|
NHLBI |
| Enhancing Recovery in Coronary Heart Disease (ENRICHD) |
8 |
2,481 |
Randomized, unmasked trial |
|
|
NHLBI |
| Epidemiologic Studies of Glargine Use and Cancer Risk (DIMS-ESGUCR) |
|
|
Multi-site retropspective study |
|
|
Sanofi-Aventis |
| Extremely Low Gestational Age Newborns (ELGAN) |
12 |
8,000 |
Observational Study |
|
|
NICHD |
| Fluvastatin Registration Program (FRP) |
68 |
2,000 |
7 Randomized, double-masked trials, open-label safety study |
|
|
|
| Hispanic Community Health Study / Study of Latinos (HCHS-SOL) |
4 |
16,000 |
Population-based prospective cohort follow-up |
|
|
NHLBI |
| Hispanic Community Health Study / Study of Latinos Youth Study (HCHS-SOLY) |
4 |
1,600 |
Cross-sectional observational study |
|
|
NHLBI |
| International Studies of CVD (INTL) |
7 |
20,000 |
4 prospective cohort follow-up, randomized, unmasked trials |
|
|
NHLBI |
| Jackson Heart Study Advisory Coordinating Center (JHS) |
1 |
6,500 |
Prospective cohort follow-up, family genetic study |
|
|
NHLBI |
| Laser Induced, Biologically Engineered Remodeling of Thermally Injured Skin Trial (LIBERTI) |
|
|
|
|
|
|
| Lipid Research Clinics Program (LRC) |
16 |
116,800 |
Prevalence Study, Prospective cohort follow-up, Randomized, double-masked trial, Family genetics study |
|
|
NHLBI |
| Longitudinal Studies of Child Abuse and Neglect (LONGSCAN) |
5 |
1,400 |
Prospective cohort follow-up |
|
|
NCCAN |
| Maternal Oral Therapy to Reduce Obstetric Risk (MOTOR) |
3 |
1,800 |
Randomized, unmasked trial |
|
|
NIDCR |
| Medical Optimization of Management of Type 2 Diabetes Complicating Pregnancy (MOMPOD) |
9 |
1,200 |
Randomized double masked placebo controlled clinical trial |
|
|
NICHD |
| Metformin in Treatment of Antipsychotic-Induced Weight Gain in Schizophrenia (METS) |
17 |
80 |
Randomized, double-masked placebo-controlled trial |
|
|
NIMH |
| MOTOR Kids (MOTORKIDS) |
3 |
332 |
Observational study |
|
|
NIDCR |
| National Strategy for Environment and Health, United Arab Emirates (UAEE) |
|
600 |
Population survey |
|
|
Environmental Agency - Abu Dhabi |
| Obesity Prevention in Native American Indians (PATHWAYS) |
4 |
1,700 |
Community randomized, single-masked trial |
|
|
NHLBI |
| Periodontal treatment to Eliminate Minority Inequality and Rural disparities in Stroke (PREMIERS) |
0 |
0 |
|
|
|
|
| Periodontitis and Vascular Events (PAVE) |
5 |
3,000 |
Randomized pilot study |
|
|
University of Buffalo |
| Precision Interventions for Severe and/or Exacerbation-Prone Asthma Network (PrecISE) |
10 |
800 |
Clinical Trial |
|
|
NHLBI |
| Predicting Responses to Standardized Pediatric Colitis Therapy (PROTECT) |
24 |
430 |
Multicenter open-label clinical trial |
|
|
Univ Connecticut, NIDDK |
| Randomized Intervention in Children with VesicoUreteral Reflux (RIVUR) |
15 |
600 |
Randomized, double-masked controlled clinical trial |
|
|
NIDDK |
| Studies of Left Ventricular Dysfunction (SOLVD) |
28 |
6,300 |
2 Randomized, double-masked trials |
|
|
NHLBI |
| Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS) |
12 |
3,200 |
Observational study |
|
|
NHLBI and COPD Foundation |
| Trial of Activity for Adolescent Girls (TAAG) |
6 |
10,000 |
2-arm group randomized trial |
|
|
NHLBI |
| Trial of Surgery & Thrombolysis in Ischemia of the Lower Extremity (STILE) |
34 |
400 |
Randomized, unmasked trial |
|
|
NHLBI |
| Vitamin Intervention for Stroke Prevention (VISP) |
56 |
3,600 |
Randomized, double-masked trial |
|
|
NHLBI |
| Women's Health Initiative (WHI) |
|
4,700 |
Observational study and clinical trials |
|
|
Fred Hutchinson Cancer Inst., NHLBI |